ArticleBreast cancer research and treatment2022

Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study.

Claire C Conley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.